{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:06:40Z","timestamp":1788350800246,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Municipal Science and Technology Plan Project of Xingtai City, Hebei Province","award":["No. 2022ZC232"],"award-info":[{"award-number":["No. 2022ZC232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23067-y","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:00:59Z","timestamp":1762884059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Shifting of the local inflammatory characteristics of diabetic macular edema manifested in SD-OCT after anti-VEGF treatment and associations with system inflammatory bioparameters"],"prefix":"10.1038","volume":"15","author":[{"given":"Rong-rong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-na","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-kun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"23067_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2019.09.025","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel, C. J. et al. Diabetic retinopathy preferred practice pattern\u00ae. Ophthalmology 127, 66\u2013145. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.025 (2020).","journal-title":"Ophthalmology"},{"key":"23067_CR2","doi-asserted-by":"publisher","unstructured":"Lee, R. et al. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2, 17. https:\/\/doi.org\/10.1186\/s40662-015-0026-2 (2015).","DOI":"10.1186\/s40662-015-0026-2"},{"key":"23067_CR3","doi-asserted-by":"publisher","unstructured":"Romero-Aroca, P. et al. Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J. Diabetes Res. 2016, 2156273. https:\/\/doi.org\/10.1155\/2016\/2156273 (2016).","DOI":"10.1155\/2016\/2156273"},{"key":"23067_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth, U. et al. Guidelines for the management of diabetic macular edema by the European society of retina specialists (EURETINA). Ophthalmologica 237, 185\u2013222. https:\/\/doi.org\/10.1159\/000458539 (2017).","journal-title":"Ophthalmologica"},{"key":"23067_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ophtha.2019.10.005","volume":"127","author":"A Rosenblatt","year":"2020","unstructured":"Rosenblatt, A. et al. A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: the European DME registry study. Ophthalmology 127, 377\u2013393. https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.005 (2020).","journal-title":"Ophthalmology"},{"key":"23067_CR6","doi-asserted-by":"publisher","unstructured":"R\u00fcbsam, A. et al.  Role of inflammation in diabetic retinopathy. Int. J. Mol. Sci. 19, 942. https:\/\/doi.org\/10.3390\/ijms19040942 (2018).","DOI":"10.3390\/ijms19040942"},{"key":"23067_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","volume":"30","author":"AP Adamis","year":"2008","unstructured":"Adamis, A. P. & Berman, A. J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol. 30, 65\u201384. https:\/\/doi.org\/10.1007\/s00281-008-0111-x (2008).","journal-title":"Semin. Immunopathol."},{"key":"23067_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1167\/iovs.17-23042","volume":"59","author":"H Lee","year":"2018","unstructured":"Lee, H. et al. Association between soluble CD14 in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with diabetic macular edema. Investig. Ophthalmol. Vis. Sci. 59, 715\u2013721. https:\/\/doi.org\/10.1167\/iovs.17-23042 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"23067_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","volume":"64","author":"H Xie","year":"2021","unstructured":"Xie, H. et al. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy. Diabetologia 64, 211\u2013225. https:\/\/doi.org\/10.1007\/s00125-020-05299-x (2021).","journal-title":"Diabetologia"},{"key":"23067_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1120672119880394","volume":"30","author":"G Panozzo","year":"2020","unstructured":"Panozzo, G. et al. An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: the European school for advanced studies in ophthalmology classification. Eur. J. Ophthalmol. 30, 8\u201318. https:\/\/doi.org\/10.1177\/1120672119880394 (2020).","journal-title":"Eur. J. Ophthalmol."},{"key":"23067_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000535199","volume":"67","author":"C Yanxia","year":"2024","unstructured":"Yanxia, C. et al. Optical coherence tomography-based grading of diabetic macular edema is associated with systemic inflammatory indices and imaging biomarkers. Ophthalmic Res. 67, 96\u2013106. https:\/\/doi.org\/10.1159\/000535199 (2024).","journal-title":"Ophthalmic Res."},{"key":"23067_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJK Guthrie","year":"2013","unstructured":"Guthrie, G. J. K. et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit. Rev. Oncol. Hematol. 88, 218\u2013230. https:\/\/doi.org\/10.1016\/j.critrevonc.2013.03.010 (2013).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"23067_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamacardio.2018.1042","volume":"3","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Association of neutrophil-to-lymphocyte ratio with mortality and cardiovascular disease in the Jackson heart study and modification by the Duffy antigen variant. JAMA Cardiol. 3, 455\u2013462. https:\/\/doi.org\/10.1001\/jamacardio.2018.1042 (2018).","journal-title":"JAMA Cardiol."},{"key":"23067_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen, Q. D. et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119, 789\u2013801. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.039 (2012).","journal-title":"Ophthalmology"},{"key":"23067_CR15","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","volume":"122","author":"DM Brown","year":"2015","unstructured":"Brown, D. M. et al. Intravitreal Aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology 122, 2044\u20132052. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.017 (2015).","journal-title":"Ophthalmology"},{"key":"23067_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","volume":"126","author":"H Zeng","year":"2008","unstructured":"Zeng, H. et al. Microglial activation in human diabetic retinopathy. Arch. Ophthalmol. 126, 227\u2013232. https:\/\/doi.org\/10.1001\/archophthalmol.2007.65 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"23067_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00417-014-2727-y","volume":"253","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Early Spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes. Graefe\u2019s Archive Clin. Experimental Ophthalmol. 253, 519\u2013525. https:\/\/doi.org\/10.1007\/s00417-014-2727-y (2015).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol."},{"key":"23067_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3928\/15428877-20090301-20","volume":"40","author":"D Shukla","year":"2009","unstructured":"Shukla, D. et al. Serous macular detachment as a predictor of resolution of macular edema with intravitreal triamcinolone injection. Ophthalmic Surg. Lasers Imaging. 40, 115\u2013119. https:\/\/doi.org\/10.3928\/15428877-20090301-20 (2009).","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"23067_CR19","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","volume":"585","author":"MB Graeber","year":"2011","unstructured":"Graeber, M. B. et al. Role of microglia in CNS inflammation. FEBS Lett. 585, 3798\u20133805. https:\/\/doi.org\/10.1016\/j.febslet.2011.08.033 (2011).","journal-title":"FEBS Lett."},{"key":"23067_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajpath.2011.04.018","volume":"179","author":"S Omri","year":"2011","unstructured":"Omri, S. et al. Microglia\/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKC\u03b6 in the Goto Kakizaki rat model. Am. J. Pathol. 179, 942\u2013953. https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.018 (2011).","journal-title":"Am. J. Pathol."},{"key":"23067_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1023\/b:nere.0000021246.96864.89","volume":"29","author":"E Ambrosini","year":"2004","unstructured":"Ambrosini, E. & Aloisi, F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 29, 1017\u20131038. https:\/\/doi.org\/10.1023\/b:nere.0000021246.96864.89 (2004).","journal-title":"Neurochem. Res."},{"key":"23067_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/aos.12812","volume":"94","author":"S Vujosevic","year":"2016","unstructured":"Vujosevic, S. et al. Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients. Acta Ophthalmol. 94, 56\u201364. https:\/\/doi.org\/10.1111\/aos.12812 (2016).","journal-title":"Acta Ophthalmol."},{"key":"23067_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/db14-0930","volume":"64","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group","year":"2015","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC. Diabetes 64, 631\u2013642. https:\/\/doi.org\/10.2337\/db14-0930 (2015).","journal-title":"Diabetes"},{"key":"23067_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/09273948.2015.1034804","volume":"24","author":"MS Kocabora","year":"2016","unstructured":"Kocabora, M. S. et al. Serum and aqueous concentrations of inflammatory markers in diabetic macular edema. Ocul. Immunol. Inflamm. 24, 549\u2013554. https:\/\/doi.org\/10.3109\/09273948.2015.1034804 (2016).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"23067_CR25","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1167\/iovs.11-7784","volume":"52","author":"SJ Woo","year":"2011","unstructured":"Woo, S. J. et al. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects. Investig. Ophthalmol. Vis. Sci. 52, 7697\u20137703. https:\/\/doi.org\/10.1167\/iovs.11-7784 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"23067_CR26","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1167\/iovs.12-11503","volume":"54","author":"JT Kim","year":"2013","unstructured":"Kim, J. T. et al. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Investig. Ophthalmol. Vis. Sci. 54, 3378\u20133384. https:\/\/doi.org\/10.1167\/iovs.12-11503 (2013).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"23067_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/IAE.0000000000000645","volume":"36","author":"H Lee","year":"2016","unstructured":"Lee, H. et al. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after anti-vegf treatment in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 36, 465\u2013475. https:\/\/doi.org\/10.1097\/IAE.0000000000000645 (2016).","journal-title":"Retina"},{"key":"23067_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.07.002","volume":"238","author":"PJ Khandelwal","year":"2011","unstructured":"Khandelwal, P. J. et al. Inflammation in the early stages of neurodegenerative pathology. J. Neuroimmunol. 238, 1\u201311. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.07.002 (2011).","journal-title":"J. Neuroimmunol."},{"key":"23067_CR29","doi-asserted-by":"publisher","unstructured":"Campochiaro, P. A.  Ocular neovascularization. J. Mol. Med. (Berlin Germany) 238, 91. https:\/\/doi.org\/10.1007\/s00109-013-0993-5 (2013).","DOI":"10.1007\/s00109-013-0993-5"},{"key":"23067_CR30","doi-asserted-by":"publisher","unstructured":"Stewart, M. W. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin. Proc. 87, 77\u201388. https:\/\/doi.org\/10.1016\/j.mayocp.2011.10.001 (2012).","DOI":"10.1016\/j.mayocp.2011.10.001"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23067-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:01:00Z","timestamp":1762884060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23067"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23067-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of the Hebei Eye Hospital, Hebei Provincial Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases ([2022KY19]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study involves human participants. All research procedures adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"39437"}}